TXA dosing for heart surgery patients on bypass
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial studies whether giving tranexamic acid (TXA) based on patient needs during heart surgery works better than a one-size-fits-all approach. It may help reduce bleeding during surgery, while monitoring for clotting-related side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for planned (elective) cardiovascular surgery that uses a heart-lung bypass machine
- You can sign written consent to join the study
- You are not pregnant
- You are not refusing blood from other people (donated/banked blood transfusions)
- You are not allergic to tranexamic acid (TXA)
- You do not have certain clotting risks or recent major stroke/heart attack
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.
This study tests whether giving a blood-clot-reducing medicine (TXA) early after an adult hip fracture helps reduce bleeding and related problems around surgery. It may help some patients getting operative fixation by improving safety during recovery.
This study compares two ways of giving tranexamic acid, a medicine that helps reduce bleeding, to people having heart bypass surgery without a heart-lung machine. It aims to see if taking the medicine as a pill is as good as getting it through an IV line.
This trial tests if taking tranexamic acid (TXA) pills for a week after knee replacement surgery helps reduce bleeding and the need for blood transfusions. You may qualify if you are having a planned first-time knee replacement with spinal anesthesia and are already scheduled for standard care.
This trial tests whether a medicine called TXA (tranexamic acid) can help reduce bleeding during breast reconstruction using your own abdominal tissue. It's for women having this surgery at UVA Medical Center.
Hear when a new Heart Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.